Professor Yaakov Shechter
Oncologist, melanoma specialist. An authoritative Israeli oncologist, specialist in immunotherapy of melanoma and professor of oncology at Tel Aviv University. Founder and director of the Ella Lemelbaum Institute for Immuno-Oncology and chair of the Forum of the Israeli Melanoma Society.
Professor Yaakov Shechter is the inspiration behind and one of the organizers of the Ella Melanoma Treatment Center, which he has headed since its founding. Together with the US National Institutes of Health, Israel's Ella Institute is the second clinical site in the world applying the most modern, including experimental, treatments for melanoma and skin cancer, which deliver unprecedented results.
- Faculty of Medicine, Tel Aviv University, Israel
- Faculty of Medicine, Hebrew University of Jerusalem, Israel
- Internship in oncology and radiotherapy, Yitzhak Rabin Medical Center, Petah Tikva, Israel
- Specialization in dermato-oncology and radiotherapy, Beilinson Medical Center, Petah Tikva, Israel
Professor Shechter is the chief developer of the experimental TIL therapy for metastatic melanoma and takes part in a number of promising clinical developments in oncodermatology.
Today Professor Shechter teaches at the Faculty of Medicine of Tel Aviv University, lectures on the treatment of skin cancers, and is the author of pioneering papers on the treatment of melanoma and skin cancer. He chairs the Forum of the Israeli Melanoma Society, belongs to the association of oncologists and clinical radiotherapists, and is a member of 11 scientific and practical organizations in Israel, Europe and the USA.
2006: awarded a prize by the Israel Cancer Association for developing an innovative immunotherapy approach to melanoma.
March 2010: named among Israel's leading oncologists by the newspaper Maariv.
- treatment of melanoma and skin cancer using the latest clinical developments of Israeli specialists and the achievements of clinical oncodermatology at the world's leading cancer institutes with which the Ella oncology center actively cooperates;
- scientific research to find new ways to fight skin cancer;
- creation of innovative individual anticancer programs to improve the quality and length of life of patients with advanced-stage melanoma.